Management & organisation

Supervisory Board

The azM Supervisory Board oversees the affairs of the Maastricht hospital in general and of the azM Board of Directors in particular. The Supervisory Board appoints the members of the azM Board of Directors and evaluates their performance.

The UM Supervisory Board oversees the general affairs of the university (including the Faculty of Health, Medicine and Life Sciences) and the policy of the UM Executive Board. In addition to its supervisory role, the UM Supervisory Board plays an important role as a sounding board and advisor to the UM Executive Board.

The azM Supervisory Board consists of the following members: 

  

T. Goedmakers, member of the Supervisory BoardT. Goedmakers, member of the Supervisory BoardT. Goedmakers, member of the Supervisory Board 

Mr. Goedmakers co-owns the family-run business Vebego International, where he was chairman of the board until 2005. As a businessman, Mr. Goedmakers is an experienced developer of people-intensive organizations and forward-thinking innovation. Since 2005, Mr. Goedmakers has been active as a supervisory director, mainly for public-sector organizations.


F. van Kasteren, member of the Supervisory BoardF. van Kasteren, member of the Supervisory BoardF. van Kasteren, member of the Supervisory Board

Mr. Van Kasteren is a partner at KPMG N.V. Amsterdam.


Y. Timmerman-Buck, member of the Supervisory BoardY. Timmerman-Buck, member of the Supervisory BoardY. Timmerman-Buck, member of the Supervisory Board

Ms. Y. Timmerman-Buck was a member of the CDA party in the Upper Chamber of the Dutch Parliament from 8 June 1999 through 1 November 2009. From 17 June 2003 to 6 October 2009 she was Speaker of the Senate, and from 2001 to 2003 she was the head of the CDA. Today, she is a member of the Council of State in The Hague.


M. de Smet, member of the Supervisory BoardM. de Smet, member of the Supervisory BoardM. de Smet, member of the Supervisory Board 

Prof. dr. M. de Smet is currently professor-departmental head of Intensive Care at the Groningen University Medical Centre. She is also active at management level. The appointment of Professor De Smet will contribute to the substantive knowledge desired by the Supervisory Board when it comes to the quality and safety of patient care.